Affiliated Hospital of Jiangsu University
16
4
4
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
19%
3 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
Role: collaborator
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
Role: collaborator
Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes
Role: collaborator
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study
Role: collaborator
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study
Role: collaborator
Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes
Role: collaborator
EROSION II: OCT Guided PPCI in STEMI
Role: collaborator
Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network
Role: collaborator
To Improve the Rate of Mother's Own Milk Feeding of Premature Infants in NICU
Role: collaborator
Improving Mother Milk Feeding Benefits in Neonatal Intensive Care Units
Role: collaborator
Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors
Role: collaborator
Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Thyroid Nodules
Role: collaborator
Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Breast Nodules
Role: collaborator
Intra-articular Injection of MSCs in Treatment of Knee OA
Role: lead
A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer
Role: collaborator
Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0
Role: collaborator
All 16 trials loaded